Assertio (ASRT) Free Cash Flow (2019 - 2026)
Assertio (ASRT) free cash flow from Jun 30, 2019 to Mar 31, 2026. The TTM Assertio (ASRT) free cash flow is -$7.09M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Assertio (ASRT) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 5 Years TTM | -35.56% |
| All Time TTM | -8.97% |
Annual Free Cash Flow change of Assertio (ASRT)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $8.56M | -130.38% |
| 2025 | -$28M | -206.70% |
| 2024 | $26M | -46.07% |
| 2023 | $49M | -37.48% |
| 2022 | $78M | +1331.99% |
| 2021 | $5.47M | -108.34% |
| 2020 | -$66M | -173.69% |
| 2019 | $89M | N/A |
Comparison Assertio (ASRT) five years free cash flow CAGR with competitors
Assertio (ASRT) five years free cash flow CAGR is -25.48%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| LNTH | Lantheus Holdings Inc | 89.22% | -450.12% |
| SBFM | Sunshine Biopharma Inc | 88.60% | -447.69% |
| ORGO | Organogenesis Holdings Inc - Class A | 87.05% | -441.60% |
| HROW | Harrow Inc | 51.26% | -301.16% |
| ANIP | ANI Pharmaceuticals Inc | 45.89% | -280.06% |
| ALKS | Alkermes plc | 36.06% | -241.52% |
| PCRX | Pacira BioSciences Inc | 27.91% | -209.53% |
| NBIX | Neurocrine Biosciences Inc | 25.83% | -201.37% |
| AMPH | Amphastar Pharmaceuticals Inc | 24.53% | -196.24% |
| COLL | Collegium Pharmaceutical Inc | 23.23% | -191.18% |
| ALVO | Alvotech | 21.39% | -183.95% |
| UTHR | United Therapeutics Corp | 12.12% | -147.55% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.21% | -140.08% |
| PAHC | Phibro Animal Health Corp - Class A | 6.13% | -124.06% |
| ZTS | Zoetis Inc - Class A | 4.90% | -119.21% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -111.48% |
| EOLS | Evolus Inc | 0.82% | -103.23% |
| BHC | Bausch Health Companies Inc | 0.61% | -102.41% |